Carbamazepine
NDC 50742-258, carbamazepine, tablet, extended release, from Ingenus Pharmaceuticals, LLC.
- Product NDC
- 50742-258
- Status
- Listed
- Labeler
- Ingenus Pharmaceuticals, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216404
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50742-258 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBAMAZEPINE200 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50742-258-01 | 50742025801 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50742-258-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/de67de85-15b3-4c27-b604-d028ce3789d0NADAC price for package 50742025801
GET /v1/drugs/nadac/50742025801
Use it
Look up 50742-258 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50742-258 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50742-258. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.